BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arslan E, Aksoy T, Gündoğan C, Şen Ç, Yılmaz Tatar S, Dursun N, Çermik TF. Metabolic Characteristics and Diagnostic Contribution of 18F-FDG PET/CT in Gastric Carcinomas. Mol Imaging Radionucl Ther 2020;29:25-32. [PMID: 32079385 DOI: 10.4274/mirt.galenos.2020.75537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Howard BA, Wong TZ. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. Radiol Clin North Am 2021;59:737-53. [PMID: 34392916 DOI: 10.1016/j.rcl.2021.06.001] [Reference Citation Analysis]
2 Xue XQ, Wang B, Yu WJ, Zhang FF, Niu R, Shao XL, Shi YM, Yang YS, Wang JF, Li XF, Wang YT. Relationship between total lesion glycolysis of primary lesions based on 18F-FDG PET/CT and lymph node metastasis in gastric adenocarcinoma: a cross-sectional preliminary study. Nucl Med Commun 2022;43:114-21. [PMID: 34406147 DOI: 10.1097/MNM.0000000000001475] [Reference Citation Analysis]
3 Abdelhakeem AA, Wang X, Waters RE, Patnana M, Estrella JS, Blum Murphy M, Trail AM, Lu Y, Devine CE, Ikoma N, Das P, Badgwell BD, Rogers JE, Ajani JA. Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy Response. Cancers (Basel) 2021;13:420. [PMID: 33498613 DOI: 10.3390/cancers13030420] [Reference Citation Analysis]
4 Dondi F, Albano D, Giubbini R, Bertagna F. 18F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review. Nucl Med Commun 2021;42:1293-300. [PMID: 34456317 DOI: 10.1097/MNM.0000000000001481] [Reference Citation Analysis]